Department of Cardiology, XiJing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Chin Med J (Engl). 2009 Nov 20;122(22):2724-7.
Currently intra-aortic balloon pump (IABP) has been widely used in patients with acute coronary syndrome (ACS) who undergo percutaneous coronary intervention (PCI). However, few studies have been done with regard to the clinical outcome and safety of IABP in assisting PCI in aged patients with ACS. The purpose of the present study was to evaluate the safety of IABP in different age groups of patients with ACS.
Data on 292 ACS patients who received IABP-assisted PCI in Shenyang General Hospital of People's Liberation Army were retrospectively analyzed. More specifically, the successful rate, mortality and complications associated with the treatment were compared between the senior (>/= 60 years old) and the non-senior (< 60 years old) groups of patients.
The attack rate of non-ST segment elevation ACS was significantly higher in the senior group than in the non-senior group (38.8% vs 21.1%, P < 0.01). The incidence of the IABP-associated complications was not significantly different between both groups (P > 0.05).
The clinical outcome and safety of IABP-assisted PCI in the elderly patients were comparable to that for the non-elderly patients.
目前主动脉内球囊反搏(IABP)已广泛应用于接受经皮冠状动脉介入治疗(PCI)的急性冠状动脉综合征(ACS)患者。然而,关于 IABP 辅助 PCI 在老年 ACS 患者中的临床疗效和安全性的研究较少。本研究旨在评估 IABP 在不同年龄组 ACS 患者中的安全性。
回顾性分析在沈阳军区总医院接受 IABP 辅助 PCI 的 292 例 ACS 患者的数据。具体来说,比较了高龄(>= 60 岁)和非高龄(< 60 岁)患者组在治疗成功率、死亡率和并发症方面的差异。
高龄组非 ST 段抬高型 ACS 的发生率明显高于非高龄组(38.8% vs 21.1%,P < 0.01)。两组患者 IABP 相关并发症的发生率无显著差异(P > 0.05)。
IABP 辅助 PCI 在老年患者中的临床疗效和安全性与非老年患者相当。